Prevalence of pharmacologically treated type 2 diabetes mellitus in 2012-2016 in Greece: Real-World Data

Panagiotis-Nikolaos Lalagkas; Spyros Polyzois; Nikolaos Papanas; Evangelia Nena; Nemi Vourli; Christos Kontogiorgis; Theodoros Constantinides

doi:10.1016/j.pcd.2022.07.001

Prevalence of pharmacologically treated type 2 diabetes mellitus in 2012-2016 in Greece: Real-World Data

Prim Care Diabetes. 2022 Oct;16(5):714-716. doi: 10.1016/j.pcd.2022.07.001. Epub 2022 Aug 1.

Authors

Panagiotis-Nikolaos Lalagkas¹, Spyros Polyzois¹, Nikolaos Papanas², Evangelia Nena¹, Nemi Vourli¹, Christos Kontogiorgis³, Theodoros Constantinides¹

Affiliations

¹ Laboratory of Hygiene and Environmental Protection, Democritus University of Thrace, Alexandroupolis, Greece.
² Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
³ Laboratory of Hygiene and Environmental Protection, Democritus University of Thrace, Alexandroupolis, Greece. Electronic address: ckontogi@med.duth.gr.

PMID: 35927164
DOI: 10.1016/j.pcd.2022.07.001

Abstract

Type 2 diabetes mellitus is a serious health disorder with a global prevalence of 6059 cases per 100,000 in 2017. By analyzing real-world data, our study found an increasing prevalence of type 2 diabetes in Greece, with the peak being 7,40 individuals per 100,000 in 2016.

Keywords: Diabetes; Prevalence; Real-world data.

MeSH terms

Diabetes Mellitus, Type 2* / diagnosis
Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / epidemiology
Greece / epidemiology
Humans
Prevalence